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Key Points Summary 
 Peripheral chemoreflex sensitization is a feature of renovascular hypertension. 
 Carotid sinus nerve denervation (CSD) has recently been shown to relieve hypertension and 
reduce sympathetic activity in other rat models of hypertension. 
 We show that CSD in renovascular hypertension halts further increases in blood pressure. 
 Possible mechanisms include improvements in baroreceptor reflex sensitivity and renal 
function, restoration of cardiac calcium signalling towards control levels and reduced neural 
inflammation. 
 Our data suggest that the peripheral chemoreflex may be a viable therapeutic target for 
renovascular hypertension. 
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Abstract: 
The peripheral chemoreflex is known to be hyper-responsive in both spontaneously hypertensive 
(SHR) and Goldblatt hypertensive (2 kidney 1 clip; 2K1C) rats. We have previously shown that carotid 
sinus nerve denervation (CSD) reduces arterial blood pressure (ABP) in SHR. Here, we show that CSD 
ameliorates 2K1C hypertension and reveal potential underlying mechanisms. Adult Wistar rats were 
instrumented to record ABP via telemetry, then underwent CSD (n=9) or sham CSD (n=9) five weeks 
after renal artery clipping, versus normal Wistar (n=5). After 21 days renal function was assessed, and 
tissue collected to assess sympathetic postganglionic intracellular calcium transients ([Ca2+]i) and 
immune cell infiltrates. Hypertensive 2K1C rats showed a profound elevation in ABP (Wistar: 98±4 
mmHg vs. 2K1C: 147±8 mmHg; p<0.001), coupled with impairments in renal function and baroreflex 
sensitivity, increased neuro-inflammatory markers and enhanced [Ca2+]I  in stellate neurons (p<0.05). 
CSD reduced ABP in 2K1C+CSD rats and prevented the further progressive increase in ABP seen in 
2K1C+sham CSD rats, with a between-group difference of 14±2mmHg by Week 3 (p<0.01), 
accompanied by improvements in both baroreflex control and spectral indicators of cardiac sympatho-
vagal balance. Furthermore, CSD improved protein and albuminuria, decreased [Ca2+]i evoked 
responses from stellate neurons, and reduced indicators of brainstem inflammation. In summary, CSD 
in 2K1C rats reduces the hypertensive burden and improves renal function. This may be mediated by 
improvements in autonomic balance, functional remodelling of post-ganglionic neurones and reduced 
inflammation. Our results suggest that the peripheral chemoreflex may be considered as a potential 
therapeutic target for controlling renovascular hypertension. 
 
 
Abbreviations: 
2K1C – two kidney, one clip hypertension; CSD – carotid sinus denervation; SHR – spontaneously 
hypertensive rat; ABP – arterial blood pressure; MAP – mean arterial pressure; HR – heart rate; Ang 
II – angiotensin II; AT1-R – angiotensin type 1 receptor; NaCN – sodium cyanide. 
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Introduction 
Clinical renovascular hypertension occurs when the renal artery is narrowed, predominantly due to 
atherosclerosis (70-90% of cases) or less commonly due to dysplasia. It usually involves the ostium 
and proximal third of the main renal artery and the peri-renal aorta (Safian & Textor, 2001; Lopez-
Novoa et al., 2011). Renovascular hypertension affects approximately 6% of the elderly population, 
regardless of race or sex (Hansen et al., 2002; Piecha et al., 2012; Weber, 2014). For many years the 
Goldblatt or two kidney-one clip (2K1C) experimental model has been used to study renovascular 
hypertension (Goldblatt et al., 1934) and has been adopted herein. 
In both the 2K1C model, and in human patients, renal artery stenosis is associated with a decrease in 
renal perfusion pressure, activation of the renin-angiotensin system, suppression of the baroreceptor 
reflex and increased sympathetic nerve activity (Johansson et al., 1999; Oliveira-Sales et al., 2014).  
Angiotensin II (Ang II) has been shown to drive increases in reactive oxygen species (ROS) production 
and inflammatory markers in renovascular hypertension (Ruiz-Ortega et al., 2006), and inhibition of 
these pathways can mitigate the increase in arterial pressure in the 2K1C model (Bivol et al., 2008).  
Previous studies in renovascular hypertensive rats have found evidence of elevated inflammatory 
markers in the heart (Nicoletti et al., 1996) and kidneys (Bivol et al., 2008; Cheng et al., 2009). We 
have previously shown that carotid sinus nerve denervation (CSD) in spontaneously hypertensive rats 
(SHR) reduces T-cell infiltration in the aorta and brainstem (McBryde et al., 2013), but it is currently 
unknown whether a similar benefit might be seen in renovascular hypertension. 
The carotid body has attracted considerable interest as a potential new treatment target for 
sympathetically-mediated cardiovascular disease (Paton et al., 2013a; Paton et al., 2013b). We have 
recently shown that removal of peripheral chemoreceptor afferents, by CSD, ameliorates 
hypertension in the spontaneously hypertensive rat (Abdala et al., 2012), in conjunction with an 
improvement in cardiac baroreceptor reflex gain and a profound (~50%) reduction in renal 
sympathetic activity (McBryde et al., 2013). In other conditions where the renin-angiotensin system is 
activated, Ang II has been shown to facilitate the release of noradrenaline from sympathetic nerves 
(Maruyama et al., 2000; Fabiani et al., 2001). Given our recent finding that peripheral chemoreceptor 
reflex sensitivity to stimulation sodium cyanide is greatly increased in 2K1C rats (Oliveira-Sales et al., 
2016), we hypothesised that CSD would alleviate hypertension and improve renal function in 
experimental renovascular hypertension. We further hypothesized that the mechanisms underlying 
the responses to CSD may involve improvements in baroreceptor reflex function, reductions in 
inflammation and sympathetic post-ganglionic remodelling. 
Methods 
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Ethical Approvals  
Procedures were carried out according to the United Kingdom Home Office Guidelines Scientific 
Procedures Act of 1986. Rats were housed individually, given normal rat chow and drinking water ad 
libitum, and kept on a 14/10hour light/dark cycle. Animals were divided into three experimental 
groups: (1) two kidney one clip sham carotid sinus denervated (2K1C+sham CSD; n=9), (2) two kidney 
one clip carotid sinus denervated (2K1C+CSD; n=9) and (3) age-matched normotensive Wistar controls 
(Wistar; n=5). All surgeries were conducted under aseptic conditions, with animals anesthetised with 
ketamine (60mg/kg,Vetalar, Zoetis, London, UK) and medetomidine (250 μg/kg, Elanco Animal Health, 
Hampshire, UK) via intramuscular injection. The level of anaesthesia was checked frequently by testing 
limb withdrawal reflexes. Body temperature was regulated using a feedback-controlled heating pad 
(Harvard Apparatus, Cambridge, UK). Post-operatively non-steroidal anti-inflammatory pain relief was 
given (0.004ml/100g of Metacam, Boehringer Ingelheim, Germany) for 3 days following surgery. At 
the completion of the experimental protocol, animals were anesthetised with isofluorane, then 
euthanized with an intraperitoneal injection of sodium pentobarbital (100mg/kg). 
Goldblatt Model of Hypertension (two kidney one clip, 2K1C) 
Male Wistar rats (150-180g) were anaesthetized The left renal artery was accessed via a 
retroperitoneal incision, and a silver clip with an internal width of 0.2mm was used to partially obstruct 
the artery, as described previously (Oliveira-Sales et al., 2014). On completion of the surgery, 
anaesthesia was reversed with a subcutaneous injection of atipamezole (1mg/kg, Antisedan, Zoetis, 
London, UK), and the animals returned to a warm recovery box. 
Carotid sinus nerve denervation (CSD) 
Bilateral carotid sinus nerve denervation was performed five weeks after renal artery clipping, using a 
surgical approach as described previously (Abdala et al., 2012; McBryde et al., 2013). Briefly, the 
carotid sinus was accessed via a ventral midline neck incision, the carotid sinus nerve branches 
removed and the adventitia of the bifurcation and the internal carotid artery carefully stripped. Sham-
operated rats underwent the same surgical procedures but the carotid sinus nerves were left intact. 
Experimental design 
Four weeks after the implantation of renal clips, rats were instrumented to record systemic arterial 
pressure via wireless telemetry (Data Sciences International Ltd), and a catheter was inserted into the 
femoral vein and externalized between the scapulae, as described previously (Waki et al., 2006; 
McBryde et al., 2013). After five days of recovery, a baseline period was recorded. Carotid sinus 
denervation (CSD) or Sham CSD was performed five weeks after renal artery clipping. Renal function 
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was tested in each group 21 days after CSD (2K1C+CSD) or sham surgery (2K1C+sham CSD) and in aged 
matched control animals (Wistar). Chemoreflex sensitivity was assessed before and after CSD or sham 
CSD, with an i.v. bolus infusion of sodium cyanide (NaCN; 120 μg/kg i.v.).  
Cardiac baroreflex sensitivity analysis  
Bradycardic and tachycardic reflex responses produced by bolus infusion of phenylephrine (0.1 mg 
ml−1, I.V.) and sodium nitroprusside (0.1 mg ml−1, I.V.) (Sigma-Aldrich Co, UK) were measured to 
generate baroreflex function curves, as previously reported (Abdala et al., 2012; Lincevicius et al., 
2015). Values of matching SBP variations with reflex heart rate (HR) responses were plotted separately 
for each vasoactive drug to create linear regression curves for each group, and their slopes were 
compared to evaluate changes in baroreflex sensitivity (bpm/mmHg). 
Renal function 
Renal function was studied as previously described (McBryde et al., 2013; Pijacka et al., 2015). Briefly, 
animals were housed in metabolic cages with free access to food and water for 24h. Blood was 
collected from the tail vein, and was kept on ice until centrifugation. Plasma and urine creatinine were 
measured by the improved Jaffe method (Jaffe, 1886), with the commercially available QuantiCrom 
Creatinine Assay Kit (DICT-500, Universal Biologicals, Cambridge, UK). Creatinine clearance was 
estimated as: urinary creatinine [µmol/L] x urine volume produced in 24 h [mL])/(plasma creatinine 
[µmol/L] x 1440 [min] (Cornock et al., 2010). Urinary albumin was measured by the improved 
bromocresol green (BCG) method, with the commercially available Albumin Assay (Randox 
Laboratories Ltd, Crumlin, UK), and total protein was measured by the Lowry method (Lowry et al., 
1951)with the DC Protein Assay Kit (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK).  
Primary Cultures of Dissociated Sympathetic Neurons 
Sympathetic neurons were isolated using a previously published method (Shanks et al., 2013). 
Following euthanasia, the stellate and mesenteric ganglia were removed from rats and isolated 
enzymatically with collagenase and trypsin. Experiments were performed 2-3 days after plating. In 
addition to the 2K1C+sham CSD and 2K1C+CSD groups mentioned above, neurones were also cultured 
from separate 2K1C (n=8) and normotensive Wistar (n=8) groups. 
Measurement of Free Intracellular Calcium Concentration 
[Ca2+]i was determined in single neurons using Fura-2 acetoxymethyl ester (Fura-2/AM, 2μmol/L) as 
previously described(Li et al., 2012). Loaded neurons were imaged with a QICLICK digital CCD camera 
(Photometrics) connected to an OptoLED fluorescence imaging system (Cairn Research Ltd) housed 
on an inverted Nikon microscope equipped with a 40×, oil-immersion objective. The cover slip 
containing the neurons was placed into a temperature-controlled (36±0.5 °C), gravity fed, perfusion 
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chamber (volume: 100 μl), perfused with Tyrode solution at a flow rate of 2 ml/min. The evoked [Ca2+]i 
transient was evaluated by 30 s exposure to 50 mmol/L KCl (with equimolar reduction in NaCl) in the 
Tyrode solution. Fura-2AM was excited alternately at 355 and 380 nm and the emitted at 510 nm. 
Fluorescence excitation ratios were calculated.  
FACS analysis of cellular inflammation 
Analyses of T cells and macrophages in tissue homogenates of the aorta and brainstem were 
performed as recently described (McBryde et al., 2013) using fluorescence-activated cell sorting 
(FACS). To analyze leukocytes in the aorta and brain, tissue was digested using collagenase type IX 
(125u/ml); collagenase type IS (450U/ml) and hyaluronidase IS (60U/ml) dissolved in 20 mM HEPES-
PBS buffer for 30 minutes at 37o C, while constantly agitated. The dissolved tissue was then passed 
through a 70μ sterile filter (Falcon, BD), yielding a single cell suspension. An additional step was 
applied for brain tissue using a 30% / 70% percoll gradient to separate out the mononuclear cell layer.  
All cells were then washed twice with FACS buffer (0.5% bovine serum albumin in PBS) then counted, 
stained and analyzed using multi-color flow cytometry. Antibodies (BD Biosciences) used for staining 
were as follows: V450 anti-CD45; anti-CD3 PerCP-eFluor® 710 and anti-macrophage markers. After 
immuno-staining, cells were re-suspended in FACS buffer and analysed immediately on a LSR-II flow 
cytometer with DIVA software (Becton Dickinson). Data were analysed with FlowJo software (Tree 
Star Inc., Ashland, Oregon, USA) and an initial gate was applied to exclude cell debris from the analysis.  
CD45 positive cells were identified as leukocytes within the tissue cell suspension and T cells and 
macrophages were identified with above antibodies.  
Data Acquisition and Analysis 
Blood pressure telemetry data were acquired and analysed using purpose-written scripts in Spike2 
(CED Ltd, Cambridge, UK). Heart rate (HR), respiratory rate (RR) and spectral parameters, including 
spontaneous cardiac baroreflex gain (sBRG) were obtained from the arterial waveform data, as 
described previously (McBryde et al., 2013). Briefly, power spectral density was computed using 
purpose-written scripts in Spike2. The following frequencies were calculated in normalized units: 
<0.27 Hz (very low frequency), 0.27–0.75 Hz (LF) and 0.75–3.3 Hz (HF). The ratio of the LF to the HF 
component was used as an indicator of cardiac sympatho-parasympathetic balance. Spontaneous 
baroreflex gain was computed and respiratory rate was inferred from the peaks of respiratory 
modulation of the systolic pressure frequency spectrum. Averaged data were expressed as the daily 
average mean or as the within-animal change from baseline.  
Statistical analysis 
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Data were analysed by GraphPad Prism (Version 6.05). Once normal distribution was confirmed, 
between groups statistical differences were analysed using a one-way ANOVA, with Newman-Keuls 
post-hoc comparisons. Within-group analyses were performed as the comparison between Baseline 
(Days -5 to 0) and Week 3 (Days 14-21) by repeated measures ANOVA and the Holm-Sidek multiple 
comparisons test. The type of post-hoc analysis performed is indicated in each figure legend. The level 
of statistical significance was defined as P<0.05. All results are presented as mean±SEM.  
Results 
Cardiovascular Responses to Carotid Sinus Nerve Denervation (CSD) 
Prior to CSD/sham surgeries, baseline mean arterial pressure (MAP) was significantly elevated after 5 
weeks of renal artery clipping in both 2K1C groups compared to normotensive control rats (Wistar: 
98±4 mmHg vs. 2K1C+CSD: 142±8 mmHg and 2K1C+sham CSD: 147±8 mmHg; p<0.001) and there was 
no significant different in the level of hypertension between the two 2K1C rat groups. At this time rats 
were either sham operated or underwent CSD. In the three weeks following sham-CSD surgery arterial 
pressure continued to gradually increase, reaching a level 8±2mmHg above baseline (p<0.01). In 
contrast, 2K1C+CSD animals showed a decrease in MAP by day 21 (-6±2mmHg; p=0.02). Thus, a 
between-group comparison found that MAP was 14±2mmHg lower in 2K1C+CSD versus 2K1C+sham 
CSD animals (Figure 1; p<0.01). The day/night difference was similar between Wistar and 2K1C rats 
(6.4±0.8 vs 3.8±2 mmHg; p=0.28), and was not changed after CSD (4.6±2 vs 3.7±1.6 mmHg; p=0.83). 
Respiration rate was not significantly different at baseline between groups (75±1 vs 76±2 breaths.min-
1), but fell by 9±1breaths.min-1around day 5 in 2K1C+CSD but not 2K1C+sham CSD rats (p<0.01). 
Respiration recovered to baseline levels by day 8, with no significant difference from either baseline, 
or between groups for the remainder of the experiment (Figure 1). 
Baseline heart rate was not significantly different between 2K1C and normotensive rats (Wistar: 345±7 
bpm vs. 2K1C+sham CSD: 346±7 bpm and 2K1C+CSD: 352±8 bpm).  There were no statistically 
significant changes in heart rate after CSD. 
Spontaneous baroreflex gain (sBRG) was significantly reduced in 2K1C hypertension compared to 
Wistar rats (-1.3±0.13 vs -2.3±0.08 bpm/mmHg), but did not significantly differ within or between 
groups following CSD or sham-CSD surgery (Figure 1). The low frequency: high frequency ratio of pulse 
interval (LF:HF) was significantly lower in both 2K1C groups compared to Wistar control rats 
(0.23±0.02 and 0.25±0.03 vs 0.39±0.04; p>0.01). Over the 21 day recording window the LF:HF ratio 
increased in 2K1C+sham CSD rats (0.23±0.02 to 0.32±0.03; p<0.05), but not 2K1C+CSD rats (0.25±0.02 
to 0.25±0.03; p=0.69), leaving a significant between groups difference by Week 3 (Figure 1; p<0.05). 
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This indicates that CSD may prevent further deterioration in cardiac sympatho-vagal balance in 2K1C 
rats. The low frequency component of SBP decreased from baseline by Day 21 in 2K1C+CSD rats 
(2.9±0.3 to 2.1±0.3 mmHg2, Figure 1; p<0.05). 
Chemoreflex and baroreflex responses to CSD 
The success of CSD was confirmed with 2K1C+CSD rats showing  little or no arterial pressure response 
and no bradycardia response (ΔHR: 2K1C+sham CSD -191.8±30.5; 2K1C+CSD -4.4±3.6; Wistar -
182.9±48.0) to transient  sodium cyanide activation of the chemoreflex, compared to the powerful 
pressor response seen in sham CSD rats (P<0.001; Figure 2A).  2K1C+CSD rats also exhibited an 
improved tachycardic response to induced falls in blood pressure, compared to 2K1C+sham CSD 
animals (Figure 2B; p<0.05).  However, the bradycardic response to induced increases in blood 
pressure was not significantly different between 2K1C+CSD and 2K1C+sham CSD rats (Figure 2B; 
p=0.1). 
Renal Function after CSD  
2K1C hypertension was associated with increased plasma creatinine, decreased creatinine clearance, 
elevated albuminuria and proteinuria and increases in both water intake and urine production (Figure 
5; p<0.05 Wistar vs sham CSD). CSD did not change plasma creatinine or creatinine clearance, but did 
normalise urinary protein and albumin levels (Figure 5; p<0.05 CSD vs Wistar and sham CSD). Following 
CSD, water intake and urine production tended to decrease slightly to an intermediate level not 
significantly different to either Wistar or sham CSD groups (Figure 5). 
Inflammatory changes in the aorta and brainstem 
When compared to 2K1C+Sham CSD rats, no differences were observed in the percent of vascular 
aortic immune cell infiltrates (CD45+, CD3+ cells and Macrophages) in 2K1C+CSD rats. However, the 
percentage of macrophages in brainstem homogenates was significantly reduced in 2K1C+CSD rats 
(Figure 4, P<0.05). 
Intracellular Free Calcium Transients in Sympathetic Neurons 
During depolarization with high K+, neurones cultured from the stellate ganglia of 2K1C rats showed a 
greater increase in [Ca2+]i (2.71±0.26, n=10) when compared with those from Wistar animals 
(2.08±0.13, n=20, P<0.05). This heightened [Ca2+]i response evoked was decreased by 24% in 
2K1C+CSD rats (Figure 3 C&D;P<0.05). In contrast, no significant differences in [Ca2+]i were observed 
from neurones cultured from the mesenteric ganglia (Figure 3E) of Wistar, 2K1C or 2K1C+CSD rats. 
 
Discussion 
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Our results are the first ever demonstration that renovascular hypertension can be ameliorated by 
CSD, in the two kidney one clip rat (2K1C) model. We found that resecting carotid sinus nerves 
bilaterally five weeks after renal artery clipping reduced arterial pressure, thereby preventing the 
further increases in arterial pressure seen in sham-operated animals where the carotid nerves were 
left intact. Our observed reduction in the hypertensive burden of 2K1C rats was accompanied by some 
improvements in baroreflex control and renal function, a restoration of stellate calcium signalling and 
a reduction in neural inflammatory markers. This work is an important extension of our previous work 
demonstrating the efficacy of CSD in another experimental model of hypertension (Abdala et al., 2012; 
McBryde et al., 2013), which has identified the carotid bodies as a potential therapeutic target for 
treating refractory or essential hypertension in human patients (Paton et al., 2013b; Ratcliffe et al., 
2014).  Our current study suggests that the carotid body may be a viable therapeutic target for 
renovascular hypertension. 
We observed a significant impairment in renal function assessed after 8 weeks of renal artery clipping, 
with reduced creatinine clearance, and increased plasma creatinine, albuminuria and proteinuria, 
suggesting a breakdown in the filtration barrier. Carotid sinus nerve resection at 5 weeks post clipping, 
was observed to normalize albuminuria and proteinuria, but not other indicators of renal function 
(Figure 5). While a presumed decrease in renal sympathetic drive may contribute, we suggest that this 
may also have occurred secondary to the decrease in arterial pressure, which could itself reduce the 
excessive pressure in glomerular capillaries and reduce leakage from the intact kidney. The lack of 
improvement in other indicators of renal function such as creatinine clearance may be explained by 
an already prolonged exposure to protein in the filtrate, which can cause inflammation and scarring 
in the renal tubules, with subsequent nephron loss, and an ensuing fall in renal filtration rate which 
may be more difficult to rescue (reviewed in (Abbate et al., 2006). Thus we conclude that changes in 
renal function are not likely to be the primary mechanism for the anti-hypertensive effect of CSD in 
renovascular hypertension. 
Using both direct and indirect measures, our group has previously suggested that 2K1C hypertension 
is associated with an increase sympathetic drive, which precedes the increase in arterial pressure 
(Oliveira-Sales et al., 2014; Campos et al., 2015; Oliveira-Sales et al., 2016).  Consistent with earlier 
work (Oliveira-Sales et al., 2014; Campos et al., 2015; Oliveira-Sales et al., 2016), our current results 
show 2K1C hypertension to be associated with impaired cardiac baroreflex sensitivity and impaired 
cardiac sympatho-vagal balance (Figure 2B), which has previously been reported to contribute to the 
development and maintenance of essential hypertension (Abdala et al., 2012; McBryde et al., 2013). 
Interestingly, neither the bradycardia response to an increase in arterial pressure, nor the net 
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spontaneous baroreflex gain was observed to change with CSD. Importantly, despite the complete 
bilateral resection of the carotid sinus nerves and the removal of carotid baroreceptor input, no 
impairment in baroreflex function was seen. This result may initially be counterintuitive, but it is 
known that the aortic baroreceptors play a dominant role in mediating cardiac baroreflex in the rat 
(Pickering et al., 2008), and is furthermore consistent with our previous work, where CSD was found 
to improve baroreflex gain in the SHR model (Abdala et al., 2012). We suggest that the improvements 
in baroreceptor reflex function may be due to central remodelling following the removal of the 
antagonism of peripheral chemoreceptor overactivity. 
Analysis of the calcium transients in post-ganglionic mesenteric and stellate ganglia revealed an 
increase in stellate [Ca2+]i transients in 2K1C rats. These results indicate that CSD may be causing 
remodelling of post-ganglionic sympathetic neuronal function. This is consistent with previous results 
reported in the SHR, which also showed at the level of the end organ, abnormalities in post-ganglionic 
intracellular calcium signalling (Li et al., 2013) may result in the enhanced exocytosis and impaired re-
uptake of noradrenaline from sympathetic neuronal terminals (Li et al., 2012; Shanks et al., 2013). We 
have shown previously that activation of the peripheral chemoreflex can evoke powerful increases in 
inferior cardiac sympathetic activity (Boscan et al., 2001). Interestingly, although in the current study 
we observed attenuation of stellate [Ca2+]i transients with CSD, we did not see any corresponding 
reduction in heart rate after CSD. We suggest that any functional effects of cardiac post-ganglionic 
sympathetic remodelling are thus likely to be iono- or dromo-trophic rather than chrono-trophic; this 
is an area which warrants further investigation. It is unclear whether our observed effects of CSD on 
calcium signalling are due to a direct resetting of the arterial chemoreceptor cardiac sympathetic axis, 
or may have occurred secondary to the differences in arterial blood pressure itself – although the 
within-subject fall in blood pressure after CSD was modest, hypertension in the sham operated group 
continued to increase with time, such that at the time tissue was removed for testing, the between 
group difference was ~14mmHg. Our finding that calcium signalling in the mesenteric ganglia was not 
affected by CSD should be taken with the caveat that our tissue collection protocol was not able to 
discriminate between the clipped and unclipped kidneys. Early work has shown that renal denervation 
can mitigate hypertension and reduce sympathetic tone in the 2K1C rat, but only when the nerves 
from the clipped kidney are ablated (Katholi et al., 1982). Subsequent work has shown a similar fall in 
arterial pressure after selective renal afferent denervation by dorsal rhizotomy, but again, no effect is 
seen with a contralateral denervation (Wyss et al., 1986). This suggests that the clipped and unclipped 
renal nerves are likely to play quite different roles in the development and maintenance of 
renovascular hypertension. Thus it is perhaps not surprising that our ‘mixed approach’ did not yield 
any significant results, and any future work should attempt to tease out these differences. 
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CSD was associated with reduced brainstem macrophage infiltration compared to sham operated 
animals, consistent with our previously findings in the spontaneously hypertensive rat (McBryde et 
al., 2013). We suggest that there are several possible explanations for this observation. Firstly, the 
reduction in inflammation may simply occur secondary to the reduction in the prevailing level of 
pressure. Alternatively, given that the brainstem is a key region responsible for the regulation of 
arterial blood pressure and sympathetic activity, if the removal of carotid body input itself reduces 
brainstem inflammation, this may contribute causally to the reduction in arterial pressure. In favour 
of the latter, it has been recently reported that the generation of the sympathetic vasomotor tone 
and maintenance of hypertension in 2K1C rats is mediated by increases in reactive oxygen species 
production in the rostroventrolateral medulla (RVLM) (Oliveira-Sales et al., 2010). We speculate that 
an increase in brainstem reactive oxygen species may contribute to brainstem inflammation, or vice 
versa. Alternatively, brainstem inflammation may be triggered via an afferent feedback mechanism 
from the ischemic kidney, and/or high circulating levels of ANG II (Marvar et al., 2010; Oliveira-Sales 
et al., 2014). Further characterization of the inflammatory cells following CSD are required to 
determine the potential neuro-immune modulation in the 2K1C model of renovascular hypertension, 
and we recognise the importance of assessing whether CSD altered the inflammatory state of the 
kidney in future studies.  
Both renovascular and essential hypertension are associated with sympathetic overactivity (Johansson 
et al., 1999; Carthy, 2014; Grassi et al., 2014). Recent evidence has demonstrated that the carotid 
bodies contribute to increased sympathetic drive in several models of cardiovascular disease 
(McBryde et al., 2013; Marcus et al., 2014a). In the present study on rats with renovascular 
hypertension, CSD improved indicators of cardiac sympatho-vagal balance compared to sham 
operated animals. Although the commonly-used (Kuwahara et al., 1994; Waki et al., 2006) indirect 
methods used herein to assess autonomic tone are not universally accepted (Billman, 2013), our 
current results are consistent with both our present finding that CSD reduced [Ca]I in stellate cells 
from 2K1C rats and our previous finding that CSD reduces renal sympathetic nerve activity in another 
model of hypertension (McBryde et al., 2013). Thus, we suggest that there is a strong likelihood that 
our observed fall in arterial pressure after the removal of peripheral chemoreceptor input is due, at 
least in part, to a reduction in sympathetic drive. Although the purpose of the current study was to 
examine the impact of CSD on established renovascular hypertension, it would be an interesting future 
study to test whether CSD can prevent the onset of renovascular hypertension, as we have previously 
shown to be the case in the pre-hypertensive young SHR (Abdala et al., 2012). We predict that while 
CSD is unlikely to fully prevent renovascular hypertension, given that both chemoreflex sensitivity and 
12 
 
sympathetic outflow appear to pre-date the increase in blood pressure in 2K1C hypertension, the pre-
emptive removal of the carotid bodies may limit the degree of hypertension.  
Following CSD, we observed a transient fall in respiratory rate which returned to baseline rates within 
5 days. We have previously observed a similar response after CSD in spontaneously hypertensive, but 
not Wistar rats (Abdala et al., 2012; McBryde et al., 2013). We interpret this result to indicate that 
there is tonic drive from the peripheral chemoreceptors in both the SH and 2K1C rat, the interruption 
of which is responsible for the temporary dip in the rate of breathing, until compensatory central 
remodelling occurs. This is a further indicator of abnormal peripheral chemoreceptor function in the 
2K1C hypertensive rat. 
In terms of possible mechanisms linking renal stenosis to carotid body function, we speculate that 
these effects may be mediated in glomus cells by angiotensin II (Ang II) via type 1 angiotensin II 
receptors (AT1R), which have been shown to increase carotid body (CB) activity (Allen, 1998). In 
pathological conditions where Ang II production is chronically increased, CB chemoreceptor sensitivity 
to hypoxia and/or cyanide is enhanced, and has been linked to AT1R up-regulation (Li & Schultz, 2006; 
Li et al., 2006; Marcus et al., 2010; Peng et al., 2011; Oliveira-Sales et al., 2016). Since 2K1C 
hypertension is known to be Ang II-dependent, it is possible that increased Ang II production could 
contribute to the excitation of the glomus cells in this model.  Furthermore, the actions of Ang II on 
the AT1R have also been shown to drive inflammation (Chabrashvili et al., 2003) and facilitate the 
release of noradrenaline from sympathetic nerves (Maruyama et al., 2000; Fabiani et al., 2001), which 
is consistent with our present findings. The increased sympathetic tone seen in renovascular 
hypertension has also recently been linked to an up-regulation of AT1R in the RVLM (Lincevicius et al., 
2015). Thus, it is possible that brainstem inflammation and sympathetic overactivity in renovascular 
hypertension may be driven by elevated ANG II signalling. Healy et al found that sino-aortic 
denervation was associated with a decrease in brainstem AT1-R in normal Wistar rats (Healy et al., 
1989). This suggests that interrupting the neural reflex arcs controlling arterial pressure can directly 
impact brainstem Ang II signalling, although no attempt was made to resolve chemoreceptor versus 
baroreceptor pathways. We speculate that CSD may act, at least in part, via reducing central AT1 
receptors to reduce brainstem inflammation. This putative relationship between Ang II/AT1-R 
signalling and carotid body function in renovascular hypertension should be examined in future 
studies. 
Perspectives 
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The results presented herein give support to the concept that the carotid body should be considered 
as a potential therapeutic target in renovascular hypertension. This extends our previously published 
results showing benefit in an animal model of neurogenic hypertension (Abdala et al., 2012; McBryde 
et al., 2013), and adds to the growing body of evidence suggesting that the carotid body may be a 
suitable target in a range of cardiovascular diseases characterised by parallel changes in peripheral 
chemoreceptor function and autonomic imbalance (Del Rio et al., 2013; McBryde et al., 2013; 
Niewinski et al., 2013; Paton et al., 2013a; Paton et al., 2013b; Marcus et al., 2014b; Del Rio et al., 
2015; Moraes et al., 2015). Recent studies have evaluated the feasibility of both surgical resection 
(Narkiewicz et al., 2016), and a novel pharmacological compound (Pijacka et al., 2016) to selectively 
target the carotid body in resistant hypertension. Notably, renal artery stenosis remains difficult to 
identify and treat clinically. Renal function studies show that only 5-10% of patients with renal artery 
stenosis exhibit increased plasma creatinine, yet most have high arterial pressure (Safian & Textor, 
2001); thus many renovascular pathology patients may be initially misdiagnosed with essential 
hypertension. Since removing chemoreflex drive is effective in animal models of both neurogenic and 
renovascular hypertension, we suggest that the carotid body presents a viable therapeutic target 
independent of these types of hypertension. This, together with improved selective targeting of the 
carotid body, perhaps via pharmacological modulation, awaits testing. 
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Figure 1 - Cardiovascular response to carotid sinus nerve denervation (CSD) or sham surgery 
(sham-CSD) 5 weeks after induction of 2K1C renovascular hypertension. Top panels shows the 
temporal responses in mean arterial blood pressure (MAP), respiratory frequency (Resp.), heart rate 
(HR) and heart rate variability (LF:HF) responses 5 days before and 21 days after CSD or sham CSD 
surgery, (grey dashed vertical line; n=9 per group). Bottom panels show the averaged responses of 
Baseline (days -5 to 0) vs Week 3 (Days 14-21) in Wistar, 2K1C+sham CSD and 2K1C+CSD animals for 
low frequency power of systolic blood pressure (LF of SBP) and spontaneous baroreflex gain (sBRG). 
(Differences were evaluated using one-way ANOVA with Holm-Sidek posthoc comparisons; # p<0.05, 
between-groups comparison; * p<0.05 repeated measures within-subject comparison). 
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Figure 2 - Assessment of chemoreflex and baroreflex sensitivity in 2K1C+sham CSD and 2K1C+CSD 
rats. (A) Chemoreflex-induced increases in SBP by bolus infusion of sodium cyanide (NaCN; 120 μg/kg 
i.v.) were abolished after CSD; P<0.001. (B) Cardiac baroreceptor reflex curves produced with i.v. 
infusions of vasoactive drugs (sodium nitroprusside and phenylephrine) showed an increase in 
sensitivity during sodium nitroprusside infusion in 2K1C+CSD vs. 2K1C+sham CSD rats, P<0.05.  Note 
that the responses in the 2K1C+CSD occurred despite loss of carotid sinus baroreceptor inputs and 
mediated by aortic baroreceptors. Data were analysed by one-way ANOVA with Newman-Keuls 
multiple comparisons post hoc test, n=4, *p<0.05, **p<0.01, ***p<0.001. Data are presented as 
mean±SEM. 
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Figure 3 - Intracellular Free Calcium Transients in Sympathetic Neurons from the 2 kidney-1 clip-
sham carotid sinus denervation (2K1C+sham CSD), 2 kidney-1 clip-carotid sinus denervation 
(2K1C+CSD) and age matching controls (Wistar). A: (i) All neurons imaged were sympathetic as 
evidenced by tyrosine hydroxylase immuno-positivity (green) and (ii) were localised in relation to 
other nuclei stained in blue by DAPI. B: Pseudocolour-coded ratio images of Fura-2–loaded neurons 
were obtained by conventional fluorescence microscopy. Ca2+ concentrations were colour-coded 
with a basal Ca2+ concentration in blue and a high Ca2+ concentration in red. C: An example recording 
from a stellate neuron exposed to 50 mmol/L of KCl (30 seconds) depolarization resulting in a rise in 
intracellular free calcium concentration ([Ca2+]i). Note that CSD attenuated this response. D, E: 
Quantitative data showing the difference in the peak evoked [Ca2+]i between Wistar and Goldblatt 
hypertensive rats with CSD (2K1C+ CSD) or sham CSD (2K1C+sham CSD), obtained from stellate 
ganglia (D) and mesenteric ganglia (E) neurons collected and cultured from >3 rats per group. The 
numbers inside the bars refers to the number of neurons tested, with each response per neuron 
representing one K exposure. **p<0.01, ***p<0.001, 1-way ANOVA with Holm-Sidek post hoc 
comparisonst test.  
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Figure 4 - FACS data showing immune cell infiltration of vascular aortic and brainstem tissue in the 
2 kidney-1 clip (2K1C+sham CSD), 2 kidney-1 clip-carotid sinus denervation (2K1C+CSD) and age 
matching control Wistars. CSD reduced macrophage infiltration in the brainstem but had no effect 
on CD45 and CD3 expressing T cells. One-way ANOVA with Newman-Keuls multiple comparisons 
test, *p<0.05. Data are presented as mean±SEM. 
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Figure 5 
Effect of carotid sinus nerve denervation or sham surgery on renal function. Renal function was 
assessed at 21 days after carotid sinus denervation (CSD, n=10) or sham CSD (n=14) in 2K1C 
hypertensive rats, as well as in age-matched Wistar controls (n=11). 2K1C hypertension was associated 
with multiple impairments in renal function, compared to Wistar controls. CSD normalised proteinuria 
and albuminuria (p<0.05). Data were analysed by one-way ANOVA with Newman-Keuls multiple 
comparisons tests, *p<0.05, **p<0.01. Data are presented as mean±SEM. 
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